<DOC>
	<DOCNO>NCT01362959</DOCNO>
	<brief_summary>The purpose study determine whether transdermal nicotine replacement therapy safe effective treat nicotine withdrawal symptom critically ill smoke patient .</brief_summary>
	<brief_title>Nicotine Replacement Therapy Intensive Care Unit</brief_title>
	<detailed_description>Cigarette smoking remain leading cause preventable disease premature death worldwide . There 1.2 billion smoker world , half die disease cause smoking . Smoking cause 5 million death per year , present trend continue , 10 million smoker per year project die 2025 . Furthermore , abstinence highly addictive tobacco product lead withdrawal symptom . Although symptoms non-life threaten healthy hospitalize adult well describe mechanically ventilated active smoking patient . Retrospective study find high , low equal mortality critically ill patient receive nicotine replacement therapy compare patient receive nicotine replacement . Because conflict result absence randomize control trial study efficacy safety transdermal nicotine replacement therapy critically ill smoke patient clinical study conduct .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Any patient admit intensive care unit must meet follow criterion eligible study : Critically ill active smoking patient Being mechanically ventilate Start study product application within 48 hour ICU admission Expected mechanically ventilate 48 hour start application study product Any patient admit intensive care unit meet one follow criterion eligible study : Patient young 18 year Patient next kin deny research authorization Pregnancy Breastfeeding woman History chronic dementia psychosis ( Acute ) neurologic disease admission , possibly confound study objective ( TBI , stroke , ICH/SAH , seizures , meningitis , encephalitis , intracranial tumor ) Patient receive form NRT within two week admission Patient understand Dutch Patient acute myocardial infarction Patient severe cardiac arrhythmia Patient unstable deteriorate angina pectoris Patient generalize acute chronic skin disease interfere NRT absorption Patient severe hear deficiency Moribund patient Patient know hypersensibility nicotine component transdermal therapeutic system Patient know hypersensibility patch Patient participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Delirium</keyword>
	<keyword>Psychomotor Agitation</keyword>
	<keyword>Substance Withdrawal Syndrome</keyword>
	<keyword>Nicotine replacement therapy</keyword>
</DOC>